Evidence map›Paper›PMID 42904090›Full record

ArticleNew microbes and new infections2026

Prostate tissue microbiota dysbiosis associated with prostate cancer: results from the MICROPROSTK multicenter study.

R Lotte, A Gaudart, C Cruzel, S Droupy, J P Lavigne, F Bruyère, P Lanotte, E Lechevallier, G Dubourg, P E Fournier and 14 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in New microbes and new infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

R LotteLaboratoire de Bactériologie du CHU de Nice, Hôpital Archet 2, Nice, France.
A GaudartLaboratoire de Bactériologie du CHU de Nice, Hôpital Archet 2, Nice, France.
C CruzelDélégation à la Recherche Clinique et à l'Innovation du CHU de Nice, Hôpital de Cimiez, Nice, France.
S DroupyService d'Urologie du CHU de Nîmes, Hôpital Carémeau, Nîmes, France.
J P LavigneLaboratoire de Microbiologie du CHU de Nîmes, Hôpital Carémeau, Nîmes, France.
F BruyèreService d'Urologie du CHU de Tours, Hôpital Bretonneau, Tours, France.
P LanotteLaboratoire de Bactériologie du CHU de Tours, Hôpital Bretonneau, Tours, France.
E LechevallierService d'Urologie de l'APHM, Hôpital la Conception, Marseille, France.
G DubourgInstitut Hospitalo-Universitaire Méditerranée Infection, Marseille, France.
P E FournierInstitut Hospitalo-Universitaire Méditerranée Infection, Marseille, France.
R HaiderService d'Urologie du CH de Cannes, Hôpital Simone Veil, Cannes, France.
L LotteLaboratoire de Biologie du CH de Cannes, Hôpital Simone Veil, Cannes, France.
K YoussefService d'Urologie du CH de Menton, Hôpital La Palmosa, Menton, France.
A EmeryLaboratoire de Bactériologie du CHU de Nice, Hôpital Archet 2, Nice, France.
R MadanyLaboratoire de Bactériologie du CHU de Nice, Hôpital Archet 2, Nice, France.
M PayenLaboratoire de Bactériologie du CHU de Nice, Hôpital Archet 2, Nice, France.
L PfauwadelLaboratoire de Bactériologie du CHU de Nice, Hôpital Archet 2, Nice, France.
B TibiService d'Urologie du CHU de Nice, Hôpital Pasteur 2, Nice, France.
Y AhallalService d'Urologie du CHU de Nice, Hôpital Pasteur 2, Nice, France.
S ZouariService d'Urologie du CHU de Nice, Hôpital Pasteur 2, Nice, France.
I BentellisService d'Urologie du CHU de Nice, Hôpital Pasteur 2, Nice, France.
E FontasDélégation à la Recherche Clinique et à l'Innovation du CHU de Nice, Hôpital de Cimiez, Nice, France.
M DurandService d'Urologie du CHU de Nice, Hôpital Pasteur 2, Nice, France.
R RuimyLaboratoire de Bactériologie du CHU de Nice, Hôpital Archet 2, Nice, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•The prostate harbors a diverse and previously undercharacterized microbial ecosystem with species-level resolution.•Prostate cancer (PCa) patients exhibit higher microbial richness and α-diversity in prostate tissue than non PCa patients.•Distinct microbial communities are observed across prostate, urinary, and rectal niches, independent of cancer status.•

Indexed as

16S rDNA sequencingMicrobial dysbiosisPathobiontsProstate cancerProstate microbiota

Identifiers

PMID42904090
PMCPMC13682004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.